Merck trades lower after 1Q results – The trend remains bullish

Merck KGaA, the chemicals and pharmaceuticals group, posted 1Q net income surged to 458 million euros from 190 million euros in the prior-year period

Uptrend 3

Merck KGaA, the chemicals and pharmaceuticals group, posted 1Q net income surged to 458 million euros from 190 million euros in the prior-year period and adjusted EBITDA rose 27.2% on year to 1.18 billion euros on revenue of 4.37 billion euros, up 16.7%. Regarding full-year outlook, the company said: "Group EBITDA pre is expected to be in a range of between E4.35 billion and E4.85 billion. Owing to strong restrictions of economic life and declining income in the context of the Covid-19 pandemic with correspondingly adverse effects on the businesses, Merck forecasts a merely stable organic development."

From a technical perspective, the bearish gap opened this morning calls for a short term consolidation move. However, the trend remains bullish.  A pennant pattern is taking shape. (Continuation trend pattern).  The daily Relative Strength Index (RSI, 14) is above 50% and is not overbought (<70%).

As long as 95E is support, the bias is bullish. The validation of the pennant pattern would call for a new rise towards 110E and 118.4E.

Alternatively, a break below 95E would negate the bullish view and would call for a reversal down trend with 87.45E as first target.

Source: GAIN Capital, TradingView

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.